Navigation Links
Morningstar Healthcare Analysts to Discuss Top 15 Biotech Acquisition Targets on Wednesday, March 4 at 11 a.m. EST
Date:2/27/2009

CHICAGO, Feb. 27 /PRNewswire-FirstCall/ -- Morningstar, Inc. (Nasdaq: MORN), a leading provider of independent investment research, is holding a conference call for institutional investors including portfolio managers at mutual funds, hedge funds, pensions, and endowments. The topic of the call is "The Top 15 Biotech Acquisition Targets" and it will be held at 11 a.m. EST, 10 a.m. CST on Wednesday, March 4.

Damien Conover, CFA, Morningstar's equity strategist for the healthcare sector and the Morningstar Healthcare Observer institutional newsletter, will share the results of analysis conducted by Morningstar's team of 12 healthcare analysts on the 63 biotech companies they cover. The team ranked each company by its likelihood of being acquired based upon a methodology that weighed drug portfolio strength, profit-boosting power, collaborative fit, financial health, and recent stock performance.

Conover will be joined on the call by biotech analyst Karen Andersen.

Institutional investors: To obtain dial-in instructions, please RSVP with your name and company name to Heather Brilliant, Morningstar's Director of Stock Analysis, at hbrilliant@morningstar.com.

Press registration: To obtain dial-in instructions, please RSVP to Courtney Goethals Dobrow at courtney.dobrow@morningstar.com.

About Morningstar, Inc.

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offers an extensive line of Internet, software, and print-based products and services for individuals, financial advisors, and institutions. Morningstar provides data on more than 300,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time pricing data on more than 4 million global equities, commodities, derivatives, indexes, and foreign currencies. The company has operations in 19 countries and minority ownership positions in companies based in three other countries.

    (C)2009 Morningstar Inc.  All rights reserved.

     Media Contact:
     Courtney Goethals Dobrow 312-696-6241, courtney.dobrow@morningstar.com

'/>"/>
SOURCE Morningstar, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Abbott to Present at Barclays Global Healthcare Conference
2. Healthcare Executives Will Discuss How Best to Spend Economic Stimulus Money at June Conference
3. Jennifer Brownstein, of CONNEXION Healthcare, Honored as Rising Star by Healthcare Businesswomens Association
4. LAB research to present at upcoming UBS 2009 global healthcare services conference in New York
5. BMP Sunstone to Present at UBS Global Healthcare Services Conference
6. Genesis HealthCare Promotes Wendy LaBate To Senior Vice President of Operations for the Northeast Area
7. IPC The Hospitalist Company, Inc. to Present at UBS 2009 Global Healthcare Services Conference
8. AMDL First to Implement US & China-Based, GAAP-Certified Accounting Technology to Capitalize on Lucrative China Healthcare Market
9. bioMerieux Introduces Surveillance Tool to Fight Healthcare-Associated Infections
10. Malaysian Healthcare Industry Is in Good Shape
11. Keryx Biopharmaceuticals to Present at the J.P. Morgan 27th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... The Fight Against Cancer Innovation Trust (FACIT) and the ... report that Fusion Pharmaceuticals Inc. (Fusion) has closed a ... – JJDC, Inc. (JJDC) as the lead investor. Additional, ... and Genesys Capital, as well as founding investor FACIT.  ... ...
(Date:2/23/2017)... it seems everyone has a chance to express their personalities. ... and dynamic community unlike any other. The businesses that succeed ... With their newest salon in Dunwoody ... that tradition with a unique, fresh approach to head lice ... newest of 13 nationwide locations, each of them well-situated in ...
(Date:2/23/2017)... ROCHESTER, Minn. , Feb. 23, 2017 /PRNewswire/ ... a new product line of oncolytic vaccinia viruses ... Genelux Corporation as part of Genelux,s proprietary, vaccinia ... "We are excited to enter into a partnership ... time, selected oncolytic vaccinia viruses for use in ...
(Date:2/23/2017)... Baltimore, Maryland (PRWEB) , ... ... ... firm, PathSensors, Inc., announced today that in a published evaluation of multiple ... (PNNL), a U.S. Department of Energy Laboratory, PathSensors’ CANARY® biosensor threat detection ...
Breaking Biology Technology:
(Date:2/13/2017)... -- Former 9/11 Commission border counsel and Special Counsel ... of Identity Strategy Partners, LLP, today releases the ... Order: Protecting the Nation From Foreign Terrorist Entry Into ... President Trump,s ,Travel Ban, Executive Order gains more notoriety ... travel ban, it is important that our national discourse ...
(Date:2/8/2017)... 7, 2017  Aware, Inc. (NASDAQ: AWRE ), ... financial results for its quarter and year ended December 31, ... 2016 was $3.9 million compared to $6.9 million in the ... of 2016 was $0.6 million compared to $2.6 million in ... quarter of 2016 was $0.5 million, or $0.02 per diluted ...
(Date:2/7/2017)...   MedNet Solutions , an innovative SaaS-based eClinical ... research, is pleased to announce that the latest release ... flexible and award winning eClinical solution, is now available ... is a proven Software-as-a-Service (SaaS) clinical research technology platform ... also delivers an entire suite of eClinical tools to ...
Breaking Biology News(10 mins):